vs

Side-by-side financial comparison of American Integrity Insurance Group, Inc. (AII) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

American Integrity Insurance Group, Inc. is the larger business by last-quarter revenue ($68.1M vs $37.2M, roughly 1.8× Organogenesis Holdings Inc.).

American International Group, Inc. (AIG) is an American multinational finance and insurance corporation with operations in more than 80 countries and jurisdictions. As of 2023, AIG employed 25,200 people. The company operates through three core businesses: general insurance, life & retirement, and a standalone technology-enabled subsidiary. General Insurance includes Commercial, Personal Insurance, U.S. and International field operations. Life & Retirement includes Group Retirement, Individua...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

AII vs ORGO — Head-to-Head

Bigger by revenue
AII
AII
1.8× larger
AII
$68.1M
$37.2M
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AII
AII
ORGO
ORGO
Revenue
$68.1M
$37.2M
Net Profit
$20.9M
Gross Margin
30.8%
Operating Margin
43.0%
-185.1%
Net Margin
30.7%
Revenue YoY
-57.1%
Net Profit YoY
EPS (diluted)
$0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AII
AII
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$68.1M
$225.6M
Q3 25
$62.0M
$150.9M
Q2 25
$74.5M
$101.0M
Q1 25
$71.9M
$86.7M
Q4 24
$126.7M
Q3 24
$115.2M
Q2 24
$130.2M
Net Profit
AII
AII
ORGO
ORGO
Q1 26
Q4 25
$20.9M
$43.7M
Q3 25
$13.2M
$21.6M
Q2 25
$27.5M
$-9.4M
Q1 25
$38.1M
$-18.8M
Q4 24
$7.7M
Q3 24
$12.3M
Q2 24
$-17.0M
Gross Margin
AII
AII
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
AII
AII
ORGO
ORGO
Q1 26
-185.1%
Q4 25
43.0%
28.1%
Q3 25
30.3%
13.7%
Q2 25
32.3%
-12.5%
Q1 25
59.7%
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-10.7%
Net Margin
AII
AII
ORGO
ORGO
Q1 26
Q4 25
30.7%
19.4%
Q3 25
21.2%
14.3%
Q2 25
36.9%
-9.3%
Q1 25
53.0%
-21.7%
Q4 24
6.1%
Q3 24
10.7%
Q2 24
-13.1%
EPS (diluted)
AII
AII
ORGO
ORGO
Q1 26
Q4 25
$0.58
$0.31
Q3 25
$0.67
$0.11
Q2 25
$1.62
$-0.10
Q1 25
$2.78
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AII
AII
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$222.0M
$91.4M
Total DebtLower is stronger
$618.0K
Stockholders' EquityBook value
$337.0M
Total Assets
$1.2B
$520.0M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AII
AII
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$222.0M
$93.7M
Q3 25
$171.9M
$63.7M
Q2 25
$259.6M
$73.1M
Q1 25
$236.4M
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
AII
AII
ORGO
ORGO
Q1 26
Q4 25
$618.0K
Q3 25
$721.0K
Q2 25
$824.0K
Q1 25
$926.0K
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
AII
AII
ORGO
ORGO
Q1 26
Q4 25
$337.0M
$300.1M
Q3 25
$315.9M
$255.1M
Q2 25
$301.9M
$233.2M
Q1 25
$186.1M
$242.9M
Q4 24
$262.9M
Q3 24
$278.5M
Q2 24
$263.5M
Total Assets
AII
AII
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$1.2B
$598.7M
Q3 25
$1.4B
$509.8M
Q2 25
$1.6B
$461.1M
Q1 25
$1.1B
$467.4M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$443.2M
Debt / Equity
AII
AII
ORGO
ORGO
Q1 26
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AII
AII
ORGO
ORGO
Operating Cash FlowLast quarter
$138.2M
Free Cash FlowOCF − Capex
$133.2M
FCF MarginFCF / Revenue
195.6%
Capex IntensityCapex / Revenue
7.4%
Cash ConversionOCF / Net Profit
6.62×
TTM Free Cash FlowTrailing 4 quarters
$216.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AII
AII
ORGO
ORGO
Q1 26
Q4 25
$138.2M
$39.4M
Q3 25
$-7.5M
$3.1M
Q2 25
$27.4M
$-32.9M
Q1 25
$68.1M
$-19.9M
Q4 24
$10.9M
Q3 24
$8.7M
Q2 24
$4.7M
Free Cash Flow
AII
AII
ORGO
ORGO
Q1 26
Q4 25
$133.2M
$34.8M
Q3 25
$-11.9M
$844.0K
Q2 25
$26.9M
$-36.5M
Q1 25
$68.0M
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
AII
AII
ORGO
ORGO
Q1 26
Q4 25
195.6%
15.4%
Q3 25
-19.2%
0.6%
Q2 25
36.1%
-36.1%
Q1 25
94.6%
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
AII
AII
ORGO
ORGO
Q1 26
Q4 25
7.4%
2.1%
Q3 25
7.2%
1.5%
Q2 25
0.6%
3.6%
Q1 25
0.2%
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
AII
AII
ORGO
ORGO
Q1 26
Q4 25
6.62×
0.90×
Q3 25
-0.57×
0.14×
Q2 25
1.00×
Q1 25
1.79×
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons